Advertisement
CELC vs DNTH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and DNTH is a Hold.
Momentum Indicator for CELC turns positive, indicating new upward trend
CELC saw its Momentum Indicator move above the 0 level on October 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned positive. In 86 of the 98 cases, the stock moved higher in the following days. The odds of a move higher are at 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CELC's RSI Oscillator exited the oversold zone, 20 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for CELC just turned positive on October 22, 2026. Looking at past instances where CELC's MACD turned positive, the stock continued to rise in 43 of 50 cases over the following month. The odds of a continued upward trend are 86%.
Following a +5.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where CELC advanced for three days, in 249 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
CELC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CELC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for CELC entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CELC's P/B Ratio (-266.922) is very low in comparison to the industry average of (3.051). P/E Ratio (-16.214) is within average values for comparable stocks, (-0.872). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (125.677) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.647).
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. CELC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
DNTH's RSI Indicator recovers from oversold territory
The RSI Indicator for DNTH moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In 20 of the 21 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on DNTH as a result. In 86 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.
The Moving Average Convergence Divergence (MACD) for DNTH just turned positive on October 21, 2026. Looking at past instances where DNTH's MACD turned positive, the stock continued to rise in 37 of 43 cases over the following month. The odds of a continued upward trend are 86%.
Following a +4.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where DNTH advanced for three days, in 239 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
DNTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DNTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for DNTH entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 25 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. DNTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.947) is normal, around the industry mean (3.051). P/E Ratio (-19.505) is within average values for comparable stocks, (-0.872). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (125.677) among similar stocks. DNTH's P/S Ratio (2500.000) is slightly higher than the industry average of (439.647).
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CELC | DNTH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 22 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 1 Undervalued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 62 | 25 | |
SMR RATING 1..100 | 100 | 96 | |
PRICE GROWTH RATING 1..100 | 77 | 46 | |
P/E GROWTH RATING 1..100 | 23 | 25 | |
SEASONALITY SCORE 1..100 | 50 | 22 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CELC's Valuation (1) in the Miscellaneous Commercial Services industry is significantly better than the same rating for DNTH (78) in the null industry. This means that CELC’s stock grew significantly faster than DNTH’s over the last 12 months.
DNTH's Profit vs Risk Rating (25) in the null industry is somewhat better than the same rating for CELC (62) in the Miscellaneous Commercial Services industry. This means that DNTH’s stock grew somewhat faster than CELC’s over the last 12 months.
DNTH's SMR Rating (96) in the null industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that DNTH’s stock grew similarly to CELC’s over the last 12 months.
DNTH's Price Growth Rating (46) in the null industry is in the same range as CELC (77) in the Miscellaneous Commercial Services industry. This means that DNTH’s stock grew similarly to CELC’s over the last 12 months.
CELC's P/E Growth Rating (23) in the Miscellaneous Commercial Services industry is in the same range as DNTH (25) in the null industry. This means that CELC’s stock grew similarly to DNTH’s over the last 12 months.
| CELC | DNTH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 83% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 82% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 88% | 1 day ago 88% |
| MACD ODDS (%) | 1 day ago 86% | 1 day ago 86% |
| TrendWeek ODDS (%) | 1 day ago 84% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 89% |
| Advances ODDS (%) | 8 days ago 85% | 7 days ago 81% |
| Declines ODDS (%) | 3 days ago 85% | 3 days ago 87% |
| BollingerBands ODDS (%) | 1 day ago 85% | 1 day ago 86% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 87% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CELC’s FA Score shows that 2 FA rating(s) are green while DNTH’s FA Score has 2 green FA rating(s).
- CELC’s FA Score: 2 green, 3 red.
- DNTH’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CELC’s TA Score shows that 5 TA indicator(s) are bullish while DNTH’s TA Score has 5 bullish TA indicator(s).
- CELC’s TA Score: 5 bullish, 3 bearish.
- DNTH’s TA Score: 5 bullish, 3 bearish.
Price Growth
CELC (@Biotechnology) experienced а +2.42% price change this week, while DNTH (@Biotechnology) price change was +4.00% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -2.09%. For the same industry, the average monthly price growth was -12.05%, and the average quarterly price growth was -17.02%.
Reported Earning Dates
CELC is expected to report earnings on Nov 05, 2026.
DNTH is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Biotechnology (-2.09% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UCON | 24.02 | 0.01 | +0.04% |
| First Trust Smith Unconstrained Bond ETF (UCON) | |||
| FTHF | 42.92 | 0.01 | +0.02% |
| First Trust Emerging Markets Human Flourishing ETF (FTHF) | |||
| FTMU | 7.54 | -0.01 | -0.13% |
| Franklin Municipal Income ETF (FTMU) | |||
| USIN | 47.95 | -0.18 | -0.37% |
| WisdomTree 7-10 Year Laddered Treasury Fund (USIN) | |||
| EWUS | 44.87 | -0.35 | -0.77% |
| iShares MSCI United Kingdom Small Cap ETF (EWUS) | |||